| Literature DB >> 32904937 |
Gloria Nnadwa Alhassan1, Festus Fatai Adedoyin2, Festus Victor Bekun3,4, Terhemen Justine Agabo5.
Abstract
The current health pandemic that has plagued the global of which the global south-Nigeria is not insulated from is the premise for this empirical investigation. The present study relies on recent annual time-series data to conceptualize the hypothesized claim via Pesaran's Autoregressive distributed lag techniques. Empirical findings from the bounds test traces the long-run relationship between public health expenditure and economic growth over the study span. However, unlike previous studies, we introduce life expectancy and death rates in the model framework. Although health expenditure is not significant, empirical results show that a 1% increase in life expectancy and death rate increases and decreases economic growth by 3.85 and 1.84%, respectively. This suggests the need for Health Policymakers in Nigeria to implement active strategies that reduce the death rate, which is a blueprint for active engagement in the face of a global pandemic such as COVID-19.Entities:
Year: 2020 PMID: 32904937 PMCID: PMC7460965 DOI: 10.1002/pa.2302
Source DB: PubMed Journal: J Public Aff ISSN: 1472-3891
Description of variables
| Variable symbol | Description | Source |
|---|---|---|
| RGDP = GDP per capita, constant 2010 dollars | GDP per capita is gross domestic product divided by midyear population. GDP is the sum of gross value added by all resident producers in the economy plus any product taxes and minus any subsidies not included in the value of the products. It is calculated without making deductions for depreciation of fabricated assets or depletion and degradation of natural resources. Data are in constant 2010 U.S. dollars. | The World Bank |
| CAP = capital investment as a percent of GDP | Gross capital formation (formerly gross domestic investment) consists of outlays on additions to the fixed assets of the economy plus net changes in the level of inventories. Fixed assets include land improvements (fences, ditches, drains, and so on); plant, machinery, and equipment purchases; and the construction of roads, railways, and the like, including schools, offices, hospitals, private residential dwellings, and commercial and industrial buildings. Inventories are stocks of goods held by firms to meet temporary or unexpected fluctuations in production or sales, and “work in progress.” According to the 1993 SNA, net acquisitions of valuables are also considered capital formation. | The World Bank |
| LAB = labor force, million people | Labor force comprises people ages 15 and older who supply labor for the production of goods and services during a specified period. It includes people who are currently employed and people who are unemployed but seeking work as well as first‐time jobseekers. Not everyone who works is included, however. Unpaid workers, family workers, and students are often omitted, and some countries do not count members of the armed forces. Labor force size tends to vary during the year as seasonal workers enter and leave. | The World Bank |
| TOT = terms of trade, base year = 2000 | Net barter terms of trade index is calculated as the percentage ratio of the export unit value indexes to the import unit value indexes, measured relative to the base year 2000. Unit value indexes are based on data reported by countries that demonstrate consistency under UNCTAD quality controls, supplemented by UNCTAD's estimates using the previous year's trade values at the standard international trade classification three‐digit level as weights. To improve data coverage, especially for the latest periods, UNCTAD constructs a set of average prices indexes at the three‐digit product classification of the standard international trade classification revision 3 using UNCTAD's commodity Price statistics, internaχtional and national sources, and UNCTAD secretariat estimates and calculates unit value indexes at the country level using the current year's trade values as weights. | The United Nations |
| FDI = foreign direct investment, percent of GDP | Foreign direct investment is the net inflows of investment to acquire a lasting management interest (10% or more of voting stock) in an enterprise operating in an economy other than that of the investor. It is the sum of equity capital, reinvestment of earnings, other long‐term capital, and short‐term capital as shown in the balance of payments. This series shows net inflows (new investment inflows less disinvestment) in the reporting economy from foreign investors and is divided by GDP. | The World Bank |
| HEA = health spending per capita | Current expenditures on health per capita in current US dollars. Estimates of current health expenditures include healthcare goods and services consumed during each year. | The World Bank |
| LEXP = life expectancy, in years | Life expectancy at birth indicates the number of years a newborn infant would live if prevailing patterns of mortality at the time of its birth were to stay the same throughout its life. | The World Bank |
| DRT = death rate, per 1,000 people | Crude death rate indicates the number of deaths occurring during the year, per 1,000 population estimated at midyear. Subtracting the crude death rate from the crude birth rate provides the rate of natural increase, which is equal to the rate of population change in the absence of migration. | The World Bank |
Summary statistics
| Variable | Obs. | Mean |
| Min | Max |
|---|---|---|---|---|---|
| Variables at log | |||||
| LRGDP | 30 | 7.492 | 0.242 | 7.207 | 7.849 |
| LCAP | 30 | 3.302 | 0.426 | 2.701 | 3.974 |
| LLAB | 30 | 3.724 | 0.225 | 3.367 | 4.106 |
| LTOT | 30 | 4.712 | 0.497 | 3.781 | 5.415 |
| LFDI | 30 | 0.431 | 0.610 | ‐0.693 | 1.756 |
| LHEA | 19 | 4.074 | 0.582 | 2.875 | 4.681 |
| LLEXP | 30 | 3.883 | 0.060 | 3.825 | 3.988 |
| LDRT | 30 | 2.769 | 0.154 | 2.473 | 2.923 |
|
| |||||
| RGDP | 30 | 1845.52 | 452.05 | 1,348.68 | 2,563.90 |
| CAP | 30 | 29.59 | 12.18 | 14.90 | 53.19 |
| LAB | 30 | 42.46 | 9.57 | 28.98 | 60.70 |
| TOT | 30 | 124.72 | 58.73 | 43.88 | 224.77 |
| FDI | 30 | 1.85 | 1.25 | 0.50 | 5.79 |
| HEA | 19 | 66.73 | 27.84 | 17.72 | 107.87 |
| LEXP | 30 | 48.65 | 2.95 | 45.84 | 53.95 |
| DRT | 30 | 16.12 | 2.37 | 11.86 | 18.60 |
FIGURE 1Trend of variables
Pairwise correlation
| LRGDP | LCAP | LLAB | LTOT | LFDI | LHEA | LLEXP | LDRT | |
|---|---|---|---|---|---|---|---|---|
|
| 1 | |||||||
| – | ||||||||
|
| −0.9371* | 1 | ||||||
| 0.0000 | – | |||||||
|
| 0.9200* | −0.9635* | 1 | |||||
| 0.0000 | 0.0000 | – | ||||||
|
| 0.8750* | −0.8482* | 0.7967* | 1 | ||||
| 0.0000 | 0.0000 | 0.0000 | – | |||||
|
| −0.2385 | 0.2726 | −0.3587 | −0.0553 | 1 | |||
| 0.2043 | 0.145 | 0.0516 | 0.7716 | – | ||||
|
| 0.9365* | −0.8460* | 0.7938* | 0.8405* | −0.2929 | 1 | ||
| 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.2236 | – | |||
|
| 0.9725* | −0.9381* | 0.9552* | 0.8059* | −0.3298 | 0.8381* | 1 | |
| 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0751 | 0.0000 | – | ||
|
| −0.9603* | 0.9314* | −0.9612* | −0.7864* | 0.3594 | −0.8034* | −0.9980* | 1 |
| 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0511 | 0.0000 | 0.0000 | – |
FIGURE 2Recursive cusum
Model verification and validation
| Lagrange multiplier Jarque‐Bera normality test | |||
|---|---|---|---|
| Lags (p) | Chi2 |
|
|
| 1 | 2.01776 | 2 | .36463 |
| Breusch‐pagan/cook‐Weisberg test for heteroskedasticity | |||
| Chi2 (1) | 0.33 |
| .5634 |
| Ramsey RESET test | |||
| F (3, 20) | 4.75 |
| .0116 |
| Variance inflation factor | |||
| Variable | VIF | 1/VIF | |
| LLAB | 1.17 | 0.854413 | |
| LFDI | 1.14 | 0.879885 | |
| LLEXP | 1.11 | 0.899184 | |
| LCAP | 1.11 | 0.901391 | |
| LTOT | 1.09 | 0.92134 | |
| Mean VIF | 1.12 | ||
| Cameron and Trivedi's decomposition of IM‐test | |||
| Source | Chi2 |
|
|
| Heteroskedasticity | 14.11 | 20 | .825 |
| Skewness | 2.56 | 5 | .767 |
| Kurtosis | 1.3 | 1 | .2538 |
| Total | 17.97 | 26 | .8768 |
Unit root test
| Dickey‐Fuller test | Philip‐Perron | |||||||
|---|---|---|---|---|---|---|---|---|
| Variable | Level |
| First diff. |
| Level |
| First diff. |
|
| LRGDP | −0.211 | .9373 | −3.370 | .0120 | −0.464 | .8989 | −3.564 | .0065 |
| LCAP | −1.398 | .5830 | −4.726 | .0001 | −1.414 | .5754 | −4.683 | .0001 |
| LLAB | 2.669 | .9991 | −9.122 | .0000 | 2.515 | .9991 | −7.467 | .0000 |
| LTOT | −1.203 | .6722 | −4.925 | .0000 | −1.074 | .7252 | −4.947 | .0000 |
| LFDI | −3.184 | .0209 | −6.675 | .0000 | −3.307 | .0146 | −7.063 | .0000 |
| LHEA | −2.455 | .1269 | −3.502 | .0079 | −2.609 | .0911 | −3.537 | .0071 |
| LLEXP | 2.427 | .9990 | −0.891 | .7909 | 1.265 | .9964 | −7.877 | .0000 |
| LDRT | 6.067 | 1.0000 | −7.446 | .0000 | 3.104 | 1.0000 | −7.101 | .0000 |
Pesaran, Shin, and Smith (2001) ARDL bounds test
| 10% | 5% | 1% |
| ||||||
|---|---|---|---|---|---|---|---|---|---|
| Bound | I(0) | I(1) | I(0) | I(1) | I(0) | I(1) | I(0) | I(1) | F/t statistic |
| F | 2.634 | 3.923 | 3.221 | 4.704 | 4.672 | 6.63 | .013 | .065 | 4.404 |
| t | −2.559 | −3.856 | −2.934 | −4.315 | −3.718 | −5.275 | .003 | .059 | −4.208 |
ARDL regression with short‐run and long‐run equilibrium relationship
| Variables | Model 1 with health expenditure per capita | Model 2 with life Expectancy in years | Model 3 with death rate per 1,000 people |
|---|---|---|---|
| EC (−1) | −0.244 | −0.822*** | −0.835*** |
| (0.462) | (0.195) | (0.194) | |
|
| |||
| LCAP | −0.103 | −0.00235 | −0.0542 |
| (0.285) | (0.0716) | (0.0680) | |
| LLAB | −28.26 | −8.576* | −10.83** |
| (51.90) | (4.314) | (4.179) | |
| LTOT | 0.157 | 0.0247 | 0.0139 |
| (0.464) | (0.0337) | (0.0330) | |
| LFDI | −0.0691 | −0.0134 | −0.00932 |
| (0.189) | (0.0134) | (0.0130) | |
| LHEA | −0.356 | ||
| (0.956) | |||
| LLEXP | 3.847** | ||
| (1.513) | |||
| LDRT | −1.839** | ||
| (0.683) | |||
|
| |||
| D.LCAP | −0.0252 | −0.00193 | −0.0453 |
| (0.0685) | (0.0588) | (0.0565) | |
| D.LLAB | −6.888 | −7.047* | −9.043** |
| (4.369) | (3.845) | (3.998) | |
| D.LTOT | 0.0384 | 0.0203 | 0.0117 |
| (0.0542) | (0.0260) | (0.0266) | |
| D.LFDI | −0.0169 | −0.0110 | −0.00778 |
| (0.0222) | (0.0101) | (0.0102) | |
| D.LHEA | −0.0867 | ||
| (0.0777) | |||
| D.LLEXP | 3.161** | ||
| (1.476) | |||
| D.LDRT | −1.536** | ||
| (0.680) | |||
| Constant | 0.189 | 0.178* | 0.222** |
| (0.119) | (0.101) | (0.103) | |
| Observations | 18 | 28 | 28 |
| R‐squared | 0.474 | 0.557 | 0.566 |
Note: Dependent variable: LRGDP. Standard errors in parentheses.***p < .01, ** p < .05, *p < .1.
Granger causality tests
| Causality test (H0) | Statistics |
| Direction of causality |
|---|---|---|---|
| LCAP does not granger‐cause LRGDP | 3.25* | .0818 | Bi‐directional |
| LRGDP does not granger‐cause LCAP | 3.67* | .0636 | |
| LLAB does not granger‐cause LRGDP | 0.38 | .7709 | Unidirectional |
| LRGDP does not granger‐cause LLAB | 11.04** | .0032 | |
| LTOT does not granger‐cause LRGDP | 3.05* | .0922 | Unidirectional |
| LRGDP does not granger‐cause LTOT | 2.05 | .1792 | |
| LFDI does not granger‐cause LRGDP | 2.01 | .2128 | No causality |
| LRGDP does not granger‐cause LFDI | 2.37 | .1650 | |
| LHEA does not granger‐cause LRGDP | 0.13 | .7227 | Unidirectional |
| LRGDP does not granger‐cause LHEA | 29.55*** | .0002 | |
| LLEXP does not granger‐cause LRGDP | 1.50 | .2480 | No causality |
| LRGDP does not granger‐cause LLEXP | 2.36 | .1214 | |
| LDRT does not granger‐cause LRGDP | 1.31 | .3173 | No causality |
| LRGDP does not granger‐cause LDRT | 1.85 | .1790 |
Note: *, **, and *** represent significance at 10, 5, and 1%, respectively.